Skip to main content

Sanofi's Olivier Bogillot: "We hope Plaquenil will be effective enough"

Olivier Bogillot, head of Sanofi France. French drug maker Sanofi on Wednesday said it stood ready to offer the French government millions of doses of hydroxychloroquine, sold under its brand name Plaquenil, in light of a "promising" study carried out by Didier Raoult of the IHU Mediterranee Infection in Marseille.

Page not found

The content you requested does not exist or is not available anymore.